BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32364696)

  • 1. Mechanism of Catalysis by l-Asparaginase.
    Lubkowski J; Vanegas J; Chan WK; Lorenzi PL; Weinstein JN; Sukharev S; Fushman D; Rempe S; Anishkin A; Wlodawer A
    Biochemistry; 2020 May; 59(20):1927-1945. PubMed ID: 32364696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized enzymatic mechanism of catalysis by tetrameric L-asparaginases from mesophilic bacteria.
    Strzelczyk P; Zhang D; Dyba M; Wlodawer A; Lubkowski J
    Sci Rep; 2020 Oct; 10(1):17516. PubMed ID: 33060684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and structural evaluation of the antileukaemic enzyme L-asparaginase II expressed at low temperature by different Escherichia coli strains.
    de Moura WAF; Schultz L; Breyer CA; de Oliveira ALP; Tairum CA; Fernandes GC; Toyama MH; Pessoa-Jr A; Monteiro G; de Oliveira MA
    Biotechnol Lett; 2020 Nov; 42(11):2333-2344. PubMed ID: 32638188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding site.
    Borek D; Kozak M; Pei J; Jaskolski M
    FEBS J; 2014 Sep; 281(18):4097-111. PubMed ID: 25040257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E. coli L-asparaginase V27T mutant: structural and functional characterization and comparison with theoretical predictions.
    Strzelczyk P; Zhang D; Wlodawer A; Lubkowski J
    FEBS Lett; 2022 Dec; 596(23):3060-3068. PubMed ID: 36310372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geometric considerations support the double-displacement catalytic mechanism of l-asparaginase.
    Lubkowski J; Wlodawer A
    Protein Sci; 2019 Oct; 28(10):1850-1864. PubMed ID: 31423681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Data in Support of a Direct Displacement Mechanism for Type I/II L-Asparaginases.
    Schalk AM; Antansijevic A; Caffrey M; Lavie A
    J Biol Chem; 2016 Mar; 291(10):5088-100. PubMed ID: 26733195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical properties of L-asparaginase.
    Lubkowski J; Wlodawer A
    FEBS J; 2021 Jul; 288(14):4183-4209. PubMed ID: 34060231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant.
    Palm GJ; Lubkowski J; Derst C; Schleper S; Röhm KH; Wlodawer A
    FEBS Lett; 1996 Jul; 390(2):211-6. PubMed ID: 8706862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the specific function of the conserved threonine triad responsible for human L-asparaginase autocleavage and substrate hydrolysis.
    Nomme J; Su Y; Lavie A
    J Mol Biol; 2014 Jun; 426(13):2471-85. PubMed ID: 24768817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
    Nguyen HA; Su Y; Lavie A
    J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
    Huerta-Saquero A; Evangelista-Martínez Z; Moreno-Enriquez A; Perez-Rueda E
    Bioengineered; 2013; 4(1):30-6. PubMed ID: 22895060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of autocatalytic activation of plant-type L-asparaginases.
    Michalska K; Hernandez-Santoyo A; Jaskolski M
    J Biol Chem; 2008 May; 283(19):13388-97. PubMed ID: 18334484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Aspects of
    Maggi M; Scotti C
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the enigmatic mechanism of L-asparaginase II with QM/QM calculations.
    Gesto DS; Cerqueira NM; Fernandes PA; Ramos MJ
    J Am Chem Soc; 2013 May; 135(19):7146-58. PubMed ID: 23544711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-aspartylpeptides as substrates of L-asparaginases from Escherichia coli and Erwinia chrysanthemi.
    Kelo E; Noronkoski T; Stoineva IB; Petkov DD; Mononen I
    FEBS Lett; 2002 Sep; 528(1-3):130-2. PubMed ID: 12297292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from
    Andrade KCR; Homem-de-Mello M; Motta JA; Borges MG; de Abreu JAC; de Souza PM; Pessoa A; Pappas GJ; de Oliveira Magalhães P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic Role of the Substrate Defines Specificity of Therapeutic l-Asparaginase.
    Anishkin A; Vanegas JM; Rogers DM; Lorenzi PL; Chan WK; Purwaha P; Weinstein JN; Sukharev S; Rempe SB
    J Mol Biol; 2015 Aug; 427(17):2867-85. PubMed ID: 26142822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.
    Zalewska-Szewczyk B; Gach A; Wyka K; Bodalski J; Młynarski W
    Clin Exp Med; 2009 Jun; 9(2):113-6. PubMed ID: 19184328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase.
    Aghaiypour K; Wlodawer A; Lubkowski J
    Biochemistry; 2001 May; 40(19):5655-64. PubMed ID: 11341830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.